Total Funding
86
66
Total FundingVenture - Series Unknown raised
Growth Score
-3 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
16818
Ordaos creates bespoke mini-proteins to help drug hunters deliver life-saving treatments.
- Ulo Palm: Co-Founder and Board MemberPast Role: TransCelerate BioPharma, Secretary and Oversight Committee Chair
- Ziwei Liang: Co-Founder and Chief Science OfficerPast Role: Ordaos Bio, Director of Research & Development
About the Company
OrdaĆs is a human-enabled, machine-driven drug design company. We create customized mini-proteins that help pharma and biotechs around the world deliver safer and more effective life-saving treatments in a fraction of the time of traditional discovery methods. miniPRO proteins are created and evaluated in silico, and then rigorously tested in
vitro, which enables us to reliably and repeatedly deliver de novo solutions that meet our clientâs stringent requirements at scale, including novelty and probability of clinical success. At OrdaĆs, we help birth novel therapies that reduce patient suffering, improve health, and extend life.
Women Founded
